Amygdala activity after subchronic escitalopram administration in healthy volunteers: A pharmaco-functional magnetic resonance imaging study
Open accessThe DOI matches its Crossref record; 98 of the 101 references it cites were found in a registry or an index; none of the 76 sources its claims cite is checked for support yet.
Abstract
Background: Selective serotonin reuptake inhibitors (SSRIs) are used for the treatment of several conditions including anxiety disorders, but the basic neurobiology of serotonin function remains unclear. The amygdala and prefrontal cortex are strongly innervated by serotonergic projections and have been suggested to play an important role in anxiety expression. However, serotonergic function in behaviour and SSRI-mediated neurobiological changes remain incompletely understood. Aims: To investigate the neural correlates of subchronic antidepressant administration. Methods: We investigated whether the 2- to 3-week administration of a highly selective SSRI (escitalopram) would alter brain activation on a task robustly shown to recruit the bilateral amygdala and frontal cortices in a large healthy volunteer sample. Participants performed the task during a functional magnetic resonance imaging acquisition before ( n = 96) and after subchronic escitalopram ( n = 46, days of administration mean (SD) = 15.7 (2.70)) or placebo ( n = 40 days of administration mean (SD) = 16.2 (2.90)) self-administration. Results: Compared to placebo, we found an elevation in right amygdala activation to the task after escitalopram administration without significant changes in mood. This effect was not seen in the left amygdala, the dorsomedial region of interest, the subgenual anterior cingulate cortex or the right fusiform area. There were no significant changes in connectivity between the dorsomedial cortex and amygdala or the subgenual anterior cingulate cortex after escitalopram administration. Conclusions: To date, this most highly powered study of subchronic SSRI administration indicates that, contrary to effects often seen in patients with anxiety disorders, subchronic SSRI treatment may increase amygdala activation in healthy controls. This finding highlights important gaps in our understanding of the functional role of serotonin.
Overview
CoChat Summary
## TL;DR
In this double-blind pharmaco-fMRI study of healthy volunteers, 2–3 weeks of 10 mg/day escitalopram increased right amygdala activation during emotional face processing compared with placebo. The treatment did not significantly change left amygdala, sgACC, dorsal ROI, or rFFA activation, and did not alter dorsal ROI connectivity with amygdala or sgACC.
## Key findings
- At baseline, the task robustly activated the right amygdala, left amygdala, and rFFA, and deactivated the dorsal ROI and sgACC; for example, right amygdala activation had Cohen’s d = 1.17 and left amygdala d = 1.06.
- After subchronic treatment, right amygdala activation was higher in the escitalopram group than placebo in the average-parameter analysis (linear regression adjusting for age, sex, and baseline activation: p = 0.034, Cohen’s d = 0.52).
- There were no significant follow-up group differences in left amygdala (p = 0.13), dorsal ROI (p = 0.080), sgACC (p = 0.21), or rFFA (p = 0.19) activation.
- Connectivity findings at baseline were replicated, but follow-up connectivity did not differ between groups for the dorsal ROI with either amygdala seed or sgACC; the paper reports no significant group differences and notes equivalent AFNI analyses were also null.
## Methods
- Double-blind, repeated-measures, placebo-controlled design in healthy adults; participants completed fMRI before treatment and again after 12–23 days of self-administered escitalopram or placebo.
- Sample: 98 recruited; final baseline analysis n = 96. Follow-up included n = 46 escitalopram and n = 40 placebo in the abstract, with an intention-to-treat follow-up sample of total n = 86 reported later.
- Main task/analysis: an emotional face-processing block task (happy, fearful, neutral faces vs fixation cross) during fMRI; activation and generalized psychophysiological interaction connectivity were analyzed with ROI-based models in R and sensitivity analyses with AFNI small-volume correction.
## Limitations
- The paper states that compliance was assessed by self-report only, “so some non-adherence may have been present.”
- The authors state that results from healthy volunteers “may not generalise to patient populations.”
- Evident from the text: the follow-up sample was smaller than baseline because 8 participants withdrew or had technical issues and 2 were excluded for excessive motion, which limits power and comparability across timepoints.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
0 Valid · 0 Not valid · 41 Not checked · 60 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“rFFA ( p = 0.19, Cohen's d = 0.33)”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There were no significant group differences in the left amygdala ( p = 0.13, Cohen's d = 0.39)”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The results obtained with average regional activation parameters were corroborated by the small volume-corrected analyses in AFNI for the right and left amygdala (Figure 2(a)), dorsal ROI (Figure 2(b)), the sgACC (Figure 2(c)) and the rFFA (Supplemental Figure 2(a)).”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“dorsal ROI: reduced activation, p ⩽ 0.001, Cohen's d = 0.37”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“left amygdala: increased activation, p < 0.001, Cohen's d = 1.06”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
38 more claims
Create a free account to see all 101 claims and to verify the 76 references still open.
- The quote only partly states this claim. 2
- It may state two separate claims as one. 25
- Probably not a substantial claim. 43
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Connectivity
“Complementary small volume-corrected analyses in AFNI corroborated significant negative connectivity between the dorsal ROI and the sgACC only (see Supplement).”
§ Discussion
“Additionally, we found significant task-specific positive connectivity between the dorsal ROI and the sgACC which was not seen in our prior paper (Nord etal., 2019).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Activation
“Baseline. Consistent with our prior work, we found significant activation in all regions of interest at baseline (one-sample t -test, right amygdala: increased activation, p < 0.001, Cohen's d = 1.17, left amygdala: increased activation, p < 0.001, Cohen's d = 1.06, dorsal ROI: reduced activation, p ⩽ 0.001, Cohen's d = 0.37, sgACC:”
§ Discussion
“Previously, we found robust activation during emotion processing in the bilateral amygdala, dorsal ROI and rFFA, concomitant with reduced activation in the sgACC (Nord et al., 2017).”
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910 · cited 1×
“…completed the following questionnaires: The Beck Depression Inventory, Generalized Anxiety Disorder 7-item scale, The Patient Health Questionnaire 9-item scale and the State-Trait Anxiety Inventory (Beck et al., 1996; Kroenke et al., 2001; Spielberger et al., 1983; Spitzer et al., 2006).”
MethodA Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765 · cited 1×
“…completed the following questionnaires: The Beck Depression Inventory, Generalized Anxiety Disorder 7-item scale, The Patient Health Questionnaire 9-item scale and the State-Trait Anxiety Inventory (Beck et al., 1996; Kroenke et al., 2001; Spielberger et al., 1983; Spitzer et al., 2006).”
Method(1998) · PubMed · Cited by 10,216
fMRIPrep: A robust preprocessing pipeline for functional MRI
Esteban, O., Markiewicz, C. J., Blair, R. W., Moodie, C. A., Isik, A. I., Erramuzpe, A., Kent, J. D., Goncalves, M., DuPre, E., Snyder, M., et al. (2019) · Nature Methods · doi:10.1038/s41592-018-0235-4 · Cited by 3,905 · cited 1×
“Pre-processing of the fMRI data (slice time correction, motion correction, field map-based distortion correction, co-registration and normalisation) was performed with fMRIPrep version 20.2.7 (Esteban et al., 2018).”
MethodInfluentialEtkin, A., & Wager, T. D. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07030504 · Cited by 3,391 · cited 1×
“Both their activation and connectivity are associated with anxiety (Brühl et al., 2014; Carlisi and Robinson, 2018; Chavanne and Robinson, 2021; Etkin and Wager, 2007; Freitas-Ferrari et al., 2010; Goossen et al., 2019; Hattingh et al., 2012; Ipser et al., 2013; Kalisch and Gerlicher, 2014;…”
BackgroundThe amygdala: vigilance and emotion
Davis, M., & Whalen, P. J. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000812 · Cited by 2,882 · cited 1×
“The amygdala and prefrontal cortex have been frequently shown to be recruited during facial emotion-processing tasks (Davis and Whalen, 2000; Gangopadhyay et al., 2021; Phillips et al., 2003; Xu et al., 2016).”
BackgroundNeurobiology of emotion perception I: the neural basis of normal emotion perception
Phillips, M. L., Drevets, W. C., Rauch, S. L., & Lane, R. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00168-9 · Cited by 2,173 · cited 2×
“This result is also concordant with the literature, showing robust activation in the amygdala and prefrontal cortices during emotion processing (Fusar-Poli et al., 2009; Phillips et al., 2003).”
BackgroundResultInverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control
Cools, R., & D'Esposito, M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.03.028 · Cited by 1,673 · cited 1×
“…systems, it has been shown that pharmacologically increasing dopaminergic function improves cognitive function in individuals with lower baseline dopamine levels, whereas it can impair cognitive task performance in people with higher baseline dopaminergic function (Cools and D’Esposito, 2011).”
BackgroundSubgroup analysis and other (mis)uses of baseline data in clinical trials
Assmann, S. F., Pocock, S. J., Enos, L. E., & Kasten, L. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02039-0 · Cited by 1,167 · cited 1×
“For the follow-up data, equivalent analyses were conducted with R’s lm function, including baseline activation or connectivity maps as a covariate of no interest, a method shown to have the largest power to estimate post-treatment effects (Assmann et al., 2000; Vickers, 2001).”
Method
Research works printed but not linked: 2
- Beck AT, Steer RA, Brown GK (1996) Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation.
- Spielberger CD, Gorsuch RL, Lushene R, et al. (1983) Manual for the State-Trait Anxiety Scale. Washington, DC Consulting Psychologists Press.
Cited by
Navarro-Nolasco, D. A., Chi-Castañeda, D., López‐Meraz, M. L., Beltrán‐Parrazal, L., & Morgado‐Valle, C. (2025) · BMC Psychology · doi:10.1186/s40359-025-02449-x · Cited by 36
“Complementary evidence shows that escitalopram administration modulates dmPFC activity during emotional face-processing tasks, although the effects vary based on baseline neural function and participant health [72].”
A cognitive neuroscience approach to understanding aggression and its treatment
Blair, J., Habel, U., Votinov, M., Wagels, L., & Denson, T. F. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106386 · Cited by 10
Lukow, P. B., Lowther, M., Pike, A. C., Yamamori, Y., Chavanne, A. V., Gormley, S., Aylward, J., Vera, C. E., McCloud, T. L., Goble, T., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120682 · Cited by 2
Self-citation
Metadata
- Authors
- Lukow, P. B., Lowther, M., Pike, A. C., Yamamori, Y., Chavanne, A. V., Gormley, S., Aylward, J., McCloud, T., Goble, T., Rodriguez-Sanchez, J., Tuominen, E. W., Buehler, S. K., Kirk, P., & Robinson, O. J.
- Affiliations
- University College London (GB)
- École Normale Supérieure Paris-Saclay (FR)
- National Institute of Mental Health (US)
- Corresponding author
- Lukow, Paulina B
- ORCID
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2024-10-04
- Volume
- 38
- Issue
- 12
- Pages
- 1071-1082
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- PMC
- PMC11531087
- OpenAlex
- W4403129586
- Cited by
- 3
- References
- 101
- Citations by year
- 2025: 3
- FWCI
- 0.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (unspecified)
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- City Research Online (City University London) (submittedVersion)
- edoc Publication server (Humboldt University of Berlin) (submittedVersion, cc-by)
- edoc Publication server (Humboldt University of Berlin) (cc-by)
- Funders
- Medical Research Council (MR/R020817/R)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- escitalopram, amygdala activation, selective serotonin reuptake inhibitors, serotonin function, anxiety, healthy volunteers, prefrontal cortex, subgenual anterior cingulate cortex
- MeSH terms
- Escitalopram, Adult, Amygdala, Double-Blind Method, Female, Humans, Magnetic Resonance Imaging, Male, Citalopram, Selective Serotonin Reuptake Inhibitors, Prefrontal Cortex, Young Adult, Healthy Volunteers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amygdala activity after subchronic escitalopram administration in healthy volunteers: A pharmaco-functional magnetic resonance imaging study. https://app.cochat.ai/papers/10.1177/02698811241286773
- The paper
- Lukow, P. B., Lowther, M., Pike, A. C., Yamamori, Y., Chavanne, A. V., Gormley, S., Aylward, J., McCloud, T., Goble, T., Rodriguez-Sanchez, J., Tuominen, E. W., Buehler, S. K., Kirk, P., & Robinson, O. J. (2024). Amygdala activity after subchronic escitalopram administration in healthy volunteers: A pharmaco-functional magnetic resonance imaging study. Journal of Psychopharmacology. https://doi.org/10.1177/02698811241286773
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.